Polyglutamine diseases: a transcription disorder?

被引:67
作者
Okazawa, H [1 ]
机构
[1] Japan Sci Technol Corp, PRESTO, Tokyo Metropolitan Inst Neurosci, Dept Mol Therapeut, Fuchu, Tokyo 1838526, Japan
关键词
polyglutamine disease; transcription; cofactor; splicing; RNA; nuclear body; aggregation; ubiquitin; SUMO; proteasome; neuronal death;
D O I
10.1007/s00018-003-3013-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Various molecular processes including unfolded protein response, protein transport, synaptic transmission and transcription are implicated in the pathology of polyglutamine diseases caused by the expanded polyglutamine-containing proteins. More than 20 transcription-related factors have been reported to interact with disease proteins, and the pathological interaction is known to repress gene expression. The whole shape of nuclear events evoked by disease proteins is now emerging with information on these transcription-related factors and with findings on the similarity between nuclear bodies and pathological inclusion bodies. This article reviews 'transcription theory', a rapidly growing hypothesis in polyglutamine diseases.
引用
收藏
页码:1427 / 1439
页数:13
相关论文
共 128 条
[61]   CREB-binding protein sequestration by expanded polyglutamine [J].
McCampbell, A ;
Taylor, JP ;
Taye, AA ;
Robitschek, J ;
Li, M ;
Walcott, J ;
Merry, D ;
Chai, YH ;
Paulson, H ;
Sobue, G ;
Fischbeck, KH .
HUMAN MOLECULAR GENETICS, 2000, 9 (14) :2197-2202
[62]   Cleavage, aggregation and toxicity of the expanded androgen receptor in spinal and bulbar muscular atrophy [J].
Merry, DE ;
Kobayashi, Y ;
Bailey, CK ;
Taye, AA ;
Fischbeck, KH .
HUMAN MOLECULAR GENETICS, 1998, 7 (04) :693-701
[63]   Expression of extended polyglutamine sequentially activates initiator and effector caspases [J].
Miyashita, T ;
Matsui, J ;
Ohtsuka, Y ;
Mami, U ;
Fujishima, S ;
Okamura-Oho, Y ;
Inoue, T ;
Yamada, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (03) :724-730
[64]   THE T(8-21) TRANSLOCATION IN ACUTE MYELOID-LEUKEMIA RESULTS IN PRODUCTION OF AN AML1-MTG8 FUSION TRANSCRIPT [J].
MIYOSHI, H ;
KOZU, T ;
SHIMIZU, K ;
ENOMOTO, K ;
MASEKI, N ;
KANEKO, Y ;
KAMADA, N ;
OHKI, M .
EMBO JOURNAL, 1993, 12 (07) :2715-2721
[65]   Sumo, ubiquitin's mysterious cousin [J].
Müller, S ;
Hoege, C ;
Pyrowolakis, G ;
Jentsch, S .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (03) :202-210
[66]   TRANSCRIPTION FACTOR OCT-2A CONTAINS FUNCTIONALLY REDUNDANT ACTIVATING DOMAINS AND WORKS SELECTIVELY FROM A PROMOTER BUT NOT FROM A REMOTE ENHANCER POSITION IN NONLYMPHOID (HELA) CELLS [J].
MULLERIMMERGLUCK, MM ;
SCHAFFNER, W ;
MATTHIAS, P .
EMBO JOURNAL, 1990, 9 (05) :1625-1634
[67]   Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus [J].
Muratani, M ;
Gerlich, D ;
Janicki, SM ;
Gebhard, M ;
Eils, R ;
Spector, DL .
NATURE CELL BIOLOGY, 2002, 4 (02) :106-110
[68]   SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein [J].
Nakamura, K ;
Jeong, SY ;
Uchihara, T ;
Anno, M ;
Nagashima, K ;
Nagashima, T ;
Ikeda, S ;
Tsuji, S ;
Kanazawa, I .
HUMAN MOLECULAR GENETICS, 2001, 10 (14) :1441-1448
[69]   ATM: the p53 booster [J].
Nakamura, Y .
NATURE MEDICINE, 1998, 4 (11) :1231-1232
[70]   ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats [J].
Nishitoh, H ;
Matsuzawa, A ;
Tobiume, K ;
Saegusa, K ;
Takeda, K ;
Inoue, K ;
Hori, S ;
Kakizuka, A ;
Ichijo, H .
GENES & DEVELOPMENT, 2002, 16 (11) :1345-1355